KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Change in Receivables (2016 - 2025)

Historic Change in Receivables for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $156.0 million.

  • AbbVie's Change in Receivables rose 14534.88% to $156.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 89559.75%. This contributed to the annual value of -$207.0 million for FY2024, which is 21363.64% down from last year.
  • According to the latest figures from Q3 2025, AbbVie's Change in Receivables is $156.0 million, which was up 14534.88% from $17.0 million recorded in Q2 2025.
  • In the past 5 years, AbbVie's Change in Receivables ranged from a high of $1.5 billion in Q1 2025 and a low of -$590.0 million during Q3 2021
  • For the 5-year period, AbbVie's Change in Receivables averaged around $218.7 million, with its median value being $156.0 million (2025).
  • The largest annual percentage gain for AbbVie's Change in Receivables in the last 5 years was 26000.0% (2024), contrasted with its biggest fall of 1710000.0% (2024).
  • Over the past 5 years, AbbVie's Change in Receivables (Quarter) stood at $749.0 million in 2021, then plummeted by 44.46% to $416.0 million in 2022, then crashed by 181.49% to -$339.0 million in 2023, then dropped by 14.16% to -$387.0 million in 2024, then surged by 140.31% to $156.0 million in 2025.
  • Its Change in Receivables was $156.0 million in Q3 2025, compared to $17.0 million in Q2 2025 and $1.5 billion in Q1 2025.